TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Barriers to drug abuse treatment
KW - buprenorphine
KW - Buprenorphine/therapeutic use
KW - Health Services Accessibility
KW - Humans
KW - Methadone
KW - Methadone/therapeutic use
KW - Naltrexone
KW - Naltrexone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/prevention & control
KW - Pharmacotherapy for opioid use disorder
KW - United States
AU - A. Sharma
AU - S. M. Kelly
AU - S. G. Mitchell
AU - J. Gryczynski
AU - K. E. O'Grady
AU - R. P. Schwartz
A1 - 
BT - Current psychiatry reports
C5 - Opioids & Substance Use
CP - 6
CY - United States
DO - 10.1007/s11920-017-0783-9
IS - 6
JF - Current psychiatry reports
PP - United States
PY - 2017
SN - 1535-1645; 1523-3812
SP - 35
T1 - Update on Barriers to Pharmacotherapy for Opioid Use Disorders
T2 - Current psychiatry reports
TI - Update on Barriers to Pharmacotherapy for Opioid Use Disorders
U1 - Opioids & Substance Use
U2 - 28526967
U3 - 10.1007/s11920-017-0783-9
VL - 19
VO - 1535-1645; 1523-3812
Y1 - 2017
ER -